Association Between Iron Deficiency and Dementia Risk: Insights from the AMORIS Population-Based Study in Sweden

• by Mozhu Ding, Alexandra Wennberg, Stina Ek, Niklas Hammar, Katharina Schmidt-Mende, Karin Modig

• April 8, 2026

A Comprehensive Review of Monoclonal Gammopathy of Undetermined Significance

Approximately 3% to 4% of the population over the age of 50 is diagnosed with monoclonal gammopathy of undetermined significance (MGUS). It carries a lifelong risk of progression to multiple myeloma and lymphoma, requiring risk-adapted monitoring by multidisciplinary teams.

• by Kimberly Noonan, Kevin Brigle, Charise Gleason, Carrie Bellerive, Mary Steinbach, Deborah Doss

• March 4, 2026

• 17 min

Assessment of Clinical Complications and Treatment Approaches in Non-Transfusion-Dependent α- and β-Thalassemia Patients Compared to Matched Controls: A Retrospective Analysis Utilizing Administrative Claims Data in the United States

• by Arielle L. Langer, Amey Rane, Keely S. Gilroy, Jing Zhao, Louise Lombard, Carolyn R. Lew, Sujit Sheth

• March 30, 2026

Triple-negative primary myelofibrosis: a comparative analysis of phenotype, genotype, and outcome

• by Yassin A. Bashir, Ahmed A. Abdelrheem, Maymona Abdelmagid, Kaaren K. Reichard, Rong He, Cinthya J. Zepeda Mendoza, Animesh Pardanani, Naseema Gangat, Ayalew Tefferi

• January 5, 2026